Terms: = Prostate cancer AND MITF, WS2A, ENSG00000187098, 4286
17 results:
1. Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
Ravi P; Freeman D; Thomas J; Ravi A; Mantia C; McGregor BA; Berchuck JE; Epstein I; Budde P; Ahangarian Abhari B; Rupieper E; Gajewski J; Schubert AS; Kilian AL; Bräutigam M; Zucht HD; Sonpavde G
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309723
[TBL] [Abstract] [Full Text] [Related]
2. Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal prostate cancer.
Santasusagna S; Zhu S; Jawalagatti V; Carceles-Cordon M; Ertel A; Garcia-Longarte S; Song WM; Fujiwara N; Li P; Mendizabal I; Petrylak DP; Kelly WK; Reddy EP; Wang L; Schiewer MJ; Lujambio A; Karnes J; Knudsen KE; Cordon-Cardo C; Dong H; Huang H; Carracedo A; Hoshida Y; Rodriguez-Bravo V; Domingo-Domenech J
Cancer Discov; 2023 Dec; 13(12):2584-2609. PubMed ID: 37676710
[TBL] [Abstract] [Full Text] [Related]
3. MiR-182 Is Upregulated in prostate cancer and Contributes to Tumor Progression by Targeting mitf.
Stafford MYC; McKenna DJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768146
[TBL] [Abstract] [Full Text] [Related]
4. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of prostate cancer.
Truong H; Breen K; Nandakumar S; Sjoberg DD; Kemel Y; Mehta N; Lenis AT; Reisz PA; Carruthers J; Benfante N; Joseph V; Khurram A; Gopalan A; Fine SW; Reuter VE; Vickers AJ; Birsoy O; Liu Y; Walsh M; Latham A; Mandelker D; Stadler ZK; Pietzak E; Ehdaie B; Touijer KA; Laudone VP; Slovin SF; Autio KA; Danila DC; Rathkopf DE; Eastham JA; Chen Y; Morris MJ; Offit K; Solit DB; Scher HI; Abida W; Robson ME; Carlo MI
Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772
[TBL] [Abstract] [Full Text] [Related]
5. miR-4286 promotes prostate cancer progression by targeting the expression of SALL1.
Li Z; Zhao S; Wang H; Zhang B; Zhang P
J Gene Med; 2023 Jul; 25(7):e3127. PubMed ID: 31693770
[TBL] [Abstract] [Full Text] [Related]
6. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
7. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for prostate cancer in Chinese Population.
Lyu J; Zhao L; Wang F; Ji J; Cao Z; Xu H; Shi X; Zhu Y; Zhang C; Guo F; Yang B; Sun Y
Biomed Res Int; 2019; 2019():9306803. PubMed ID: 31534967
[TBL] [Abstract] [Full Text] [Related]
8. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of mitf.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract] [Full Text] [Related]
9. UV-Radiation Response Proteins Reveal Undifferentiated Cutaneous Interfollicular Melanocytes with Hyperradiosensitivity to Differentiation at 0.05 Gy Radiotherapy Dose Fractions.
Fessé P; Qvarnström F; Nyman J; Hermansson I; Ahlgren J; Turesson I
Radiat Res; 2019 Jan; 191(1):93-106. PubMed ID: 30407899
[TBL] [Abstract] [Full Text] [Related]
10. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of mitf in prostate cancer.
Valcarcel-Jimenez L; Macchia A; Martín-Martín N; Cortazar AR; Schaub-Clerigué A; Pujana-Vaquerizo M; Fernández-Ruiz S; Lacasa-Viscasillas I; Santos-Martin A; Loizaga-Iriarte A; Unda-Urzaiz M; Hermanova I; Astobiza I; Graupera M; Starkova J; Sutherland J; Barrio R; Aransay AM; Carracedo A; Torrano V
Cell Death Dis; 2018 Oct; 9(10):1041. PubMed ID: 30310055
[TBL] [Abstract] [Full Text] [Related]
11. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
12. Perceptions of masculinity and body image in men with prostate cancer: the role of exercise.
Langelier DM; Cormie P; Bridel W; Grant C; Albinati N; Shank J; Daun JT; Fung TS; Davey C; Culos-Reed SN
Support Care Cancer; 2018 Oct; 26(10):3379-3388. PubMed ID: 29654565
[TBL] [Abstract] [Full Text] [Related]
13. Prevalence of the E318K and V320I mitf germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study.
Gromowski T; Masojć B; Scott RJ; Cybulski C; Górski B; Kluźniak W; Paszkowska-Szczur K; Rozmiarek A; Dębniak B; Maleszka R; Kładny J; Lubiński J; Dębniak T
Cancer Genet; 2014 Apr; 207(4):128-32. PubMed ID: 24767713
[TBL] [Abstract] [Full Text] [Related]
14. Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
PLoS One; 2012; 7(3):e33011. PubMed ID: 22412975
[TBL] [Abstract] [Full Text] [Related]
15. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.
Mazar J; DeYoung K; Khaitan D; Meister E; Almodovar A; Goydos J; Ray A; Perera RJ
PLoS One; 2010 Nov; 5(11):e13779. PubMed ID: 21072171
[TBL] [Abstract] [Full Text] [Related]
16. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
Giovannucci E; Liu Y; Rimm EB; Hollis BW; Fuchs CS; Stampfer MJ; Willett WC
J Natl Cancer Inst; 2006 Apr; 98(7):451-9. PubMed ID: 16595781
[TBL] [Abstract] [Full Text] [Related]
17. Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores.
Brossner C; Winterholer A; Roehlich M; Dlouhy-Schütz E; Serra V; Sonnleithner M; Grubmüller KH; Pummer K; Schuster E
World J Urol; 2003 Aug; 21(3):163-6. PubMed ID: 12783171
[TBL] [Abstract] [Full Text] [Related]
